IRWD vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

IRWD

50.0
AI Score
VS
PCRX Wins

PCRX

60.1
AI Score

Investment Advisor Scores

IRWD

50score
Recommendation
HOLD

PCRX

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric IRWD PCRX Winner
Forward P/E 12.3305 8.726 PCRX
PEG Ratio -0.26 11.2121 Tie
Revenue Growth 32.6% 6.2% IRWD
Earnings Growth 125.7% -30.0% IRWD
Tradestie Score 50.0/100 60.1/100 PCRX
Profit Margin 33.4% 2.0% IRWD
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY PCRX

Relative Price Performance (Last 90 Days)

IRWD 1M: +12.8% · 3M: +6.8% PCRX 1M: -4.6% · 3M: +5.7%

Current Technical Phase

IRWD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.5% over 20 days), RSI 51

RSI (14): 50.8 · Price: $4.19

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.8 · Price: $24.69

Fundamentals Snapshot

Metric IRWD PCRX
Market Cap
Forward P/E 2.9 6.9
Trailing P/E 5.5 67.7
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.8% 0.8%
Operating Margin 0.7% 0.1%
EPS 0.75 0.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.